Romvimza Capsule
Product Images NDC 73207-302

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Romvimza (NDC 73207-302). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Deciphera Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Rom04 0001 01)

Chemical structure of Vimseltinib, the active ingredient in ROMVIMZA. The structure includes multiple aromatic rings, nitrogen atoms, oxygen atoms, and a hydration component indicated by 2 H2O molecules.*

FDA Label Image

Figure 1 (Rom04 0001 02)

A waterfall chart depicting tumor response in patients treated with ROMVIMZA (vimseltinib) compared to placebo. The Y-axis shows percentage change from baseline, and individual patient responses are represented, with responders and non-responders differentiated by filled and open bars. An arrow labeled 'Improvement' indicates direction of tumor shrinkage.*

FDA Label Image

Principal Display Panel – 14 mg Carton Label (Rom04 0001 03)

ROMVIMZA 14 mg capsules packaging label for oral use, containing 8 capsules (4-week supply) in one blister pack. The label shows the active ingredient vimseltinib and is manufactured and marketed by Deciphera Pharmaceuticals, LLC. The label includes dosage instructions, storage conditions, and contact information with a white and orange design.*

FDA Label Image

Principal Display Panel – 20 mg Carton Label (Rom04 0001 04)

Box packaging label for Romvimza 20 mg capsules (vimseltinib) by Deciphera Pharmaceuticals, LLC. The label states it contains 8 capsules (a 4-week supply) in one blister pack. It includes dosing warnings, storage instructions, and contact information. The label prominently features the Romvimza logo with dosage strength repeated on multiple sides.*

FDA Label Image

Principal Display Panel – 30 mg Carton Label (Rom04 0001 05)

Carton label for Romvimza (vimseltinib) capsules, 30 mg strength. The package contains 8 capsules, a 4-week supply, and includes one blister pack. Labels indicate the product is manufactured by Deciphera Pharmaceuticals, LLC. The label features dosage and storage instructions, stating capsules should be swallowed whole and kept out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.